Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold
Tri Murti Andayani(1*), Dwi Endarti(2), Susi Ari Kristina(3), Rifqi Rokhman(4)
(1) Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada
(2) Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada
(3) Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada
(4) Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Dranitsaris G. A pilot study to evaluate the feasibility of using willingness to pay as a measure of value in cancer supportive care: An assessment of amifostine cytoprotection. Support Care Cancer. 1997;5(6):489-499. doi:10.1007/s005200050118.
Eichler HG, Kong SX, Gerth WC, Mavros P, Jönsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Heal. 2004;7(5):518-528. doi:10.1111/j.1524-4733.2004.75003.x.
FAO. Applications of the contingent valuation method in developing countries: A Survey. FAO Econ Soc Dev Pap. 2000;146.
Frew EJ, Wolstenholme JL, Whynes DK. Comparing willingness-to-pay: Bidding game format versus open-ended and payment scale formats. Health Policy (New York). 2004;68(3):289-298. doi:10.1016/j.healthpol.2003.10.003.
King JT, Tsevat J, Lave JR, Roberts MS. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making. 2005;25(6):667-677. doi:10.1177/0272989X05282640.
Klose T. A utility-theoretic model for QALYs and willingness to pay. Health Econ. 2003;12(1):17-31. doi:10.1002/hec.697.
Martín-Fernández J, Polentinos-Castro E, del Cura-González MI, et al. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences. BMC Health Serv Res. 2014;14(1):287. doi:10.1186/1472-6963-14-287.
Nimdet K, Ngorsuraches S. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand. BMJ Open. 2015;5(10):e008123. doi:10.1136/bmjopen-2015-008123.
Paul Revill JO, James Lomas RN, Beth Woods, Alex Rollinger MS, Mark Sculpher KC. Cost-Effectiveness Threshold: Guiding Health Care Spending for Population Health Improvement.; 2015.
Pinto-Prades JL, Loomes G, Brey R. Trying to estimate a monetary value for the QALY. J Health Econ. 2009;28(3):553-562. doi:10.1016/j.jhealeco.2009.02.003.
Pinto-Prades JL, Sánchez-Martínez FI, Corbacho B, Baker R. Valuing QALYs at the end of life. Soc Sci Med. 2014;113:5-14. doi:10.1016/j.socscimed.2014.04.039.
Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P. Estimating the willingness to pay for a quality- adjusted life year in Thailand: Does the context of health gain matter? Clin Outcomes Res. 2013;5(1):29-36. doi:10.2147/CEOR.S38062
Zhao FL, Yue M, Yang H, Wang T, Wu JH, Li SC. Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis. Med Care. 2011;49:267-272. doi:10.1097/MLR.0b013e31820192cd.
DOI: https://doi.org/10.22146/jmpf.33255
Article Metrics
Abstract views : 4863 | views : 22814Refbacks
- There are currently no refbacks.
Copyright (c) 2018 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.